Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hairy and enhancer of split 6 (HES6) is a basic helix-loop-helix transcription cofactor that regulates cell differentiation in multiple cell types by antagonizing transcriptional repressors like HES1. It does not bind DNA directly, but modulates gene expression by suppressing HES1-mediated transcriptional repression and promoting the differentiation of neurons. HES6 interacts with other transcription factors through a specific tetrapeptide domain at its C-terminus and integrates signals from key developmental pathways, such as Notch signaling. Diseases associated with HES6 include brain cancer and Alagille syndrome. HES6 is not an established therapeutic target, and no drugs directly interact with it; its role is primarily in the regulation of transcription, cell fate, and differentiation during development and carcinogenesis.
Not applicable; no known drugs directly target HES6
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hairy and enhancer of split 6 (HES6).